This is different from the studies of H. Rizvi et al. and Naiyer Rizvi et al. Skoulidis et al. [22] reported comparable findings that patients with NSCLC harboring mutation in KEAP1 had a shorter PFS and overall survival (OS) than those without mutation in KEAP1. Here, KEAP1 is linked to non-small cell lung carcinoma.